As shown in Table S2–3, elevated MCP-1 concentration (log-transformed) was associated with a higher incidence of AD among NAV3 rs696468-CC carriers (HR = 2.68, 95% CI = 1.55, 4.62, p = 3.9×10− 4). Here, CCL2 is linked to Alzheimer disease.